Congratulations to Clara Van Ommen, a summer student working with WHRI member Dr. Melanie Murray

Congratulations to Clara Van Ommen, a summer student working with WHRI member Dr. Melanie Murray, who received a 2016 HIVMA Medical Student Program Award for her work on a study of HIV and ovarian aging. Clara was the only Canadian student to win this award in 2016!

Here is more information about the award and this year’s recipients:http://www.hivma.org/Medical_Students/

Congratulations to WHRI investigator Dr. Kelly Smith for receiving the 2016 Nelly Auersperg Award in Women’s Health Research

ksmith_slide

Congratulations to Dr Kelly Smith in being the recipient of the Nelly Auersperg Award.  This award supports pilot studies in women’s health which aim to generate preliminary data, test new approaches, methodologies or tools.  The funding supports activities that will enable the pursuit of more ambitious studies and foster further funding applications.

Genetic counselling should be offered to psychiatric patients: UBC study

A new University of British Columbia study shows that genetic counselling helps patients with schizophrenia, bipolar disorder and schizoaffective disorders understand and cope with their illness.

This is among the first studies to show the value of genetic counselling for psychiatric illnesses and researchers argue that the service should be made available to them. Genetic counselling is the process of helping people understand and adapt to the medical, psychological and familial implications of genetic contributions to disease.

“Traditionally genetic counselling is applied to conditions that are caused entirely by genes like Huntington’s disease,” said Jehannine Austin, an associate professor in the Depts. of Medical Genetics & Psychiatry. “Psychiatric disorders arise because of a combination of genes and experience and our study shows that genetic counselling is just as valuable for these patients.”

In a randomized controlled trial, some patients were offered counselling while others were not. The focus of the counselling sessions was to help patients understand the cause of their illness, the genetic component and how they can protect their mental health going forward.
“People with mental health problems often feel guilty, ashamed or stigmatized about where the illness came from and this has a profound effect on how they feel,” said Austin.

Austin’s previous work showed that individuals with psychiatric illness will come up with their own explanation of the cause of their illness, if they aren’t provided with an explanation that makes sense to them. These explanations are usually not grounded in evidence, and often lead people to over-estimate the risk that someone else in their family may develop psychiatric illness. In some cases, these beliefs lead people to choose not to have children, or to have fewer children than they would like. This new study showed that genetic counselling helped to clarify misconceptions, including inaccurate risk perception. The study also showed that genetic counselling holds promise for reducing stigma and increasing individuals’ perceived control over their illness; these represent areas of future work.
“People often blame themselves for the illness they are living with,” Austin said. “We helped people better understand the cause of their illness and helped them uncover issues like guilt and distress.”

These results point to the benefits of a burgeoning field of genetic counselling that focuses on psychiatric disorders. The world’s first psychiatric genetic counselling clinic is led by Austin and based out of BC Women’s Hospital, in partnership with BC Mental Health and Substance Use Services. Clinicians from Europe and the United States have trained at the clinic and are now setting up clinics in their own parts of the world.

To read the abstract and article:
http://www.psychiatrist.com/jcp/article/Pages/2016/v77n02/v77n0210.aspx

The Zika virus is an emerging concern for women and their medical providers worldwide

zikaThe Zika virus is an emerging concern for women and their medical providers worldwide. The associations with of Zika virus in pregnant women with microcephaly in their infants are very worrisome, especially since most cases in pregnant women are asymptomatic. For non-obstetric providers, sexual transmission has now been confirmed, and raises other public health issues.

Women’s Health Research Institute investigators, along with partner clinician scientists, are on the front lines nationally and internationally, studying this virus, developing management strategies and algorithms, and helping to care for exposed and infected women. Please consult your local public health and obstetrical leadership for specific guidelines.

Zika Resources:

 

 

Congratulations to Dr. Deborah Money

moneyDr. Deborah Money, has recently been appointed Executive Vice Dean, UBC, Faculty of Medicine, effective April 1, 2016. In taking her new position, she will be stepping down from her roles as Executive Director of the Women’s Health Research Institute and VP, Research at BC Women’s Hospital + Health Centre. The organizations are actively looking for a replacement for April 1, 2016.

Dr. Money will continue to work as a Reproductive Infectious Diseases (Ob/Gyn ID) physician at BC Women’s Hospital and Health Centre and to lead an active teaching and research program as a member of the UBC, PHSA and Women’s Health Research Institute communities.

It is with mixed emotions that we offer congratulations to our leader, who has been a champion for women’s health research for so long. Please join us in offering our heartfelt congratulations to Dr. Money for her years of service to the WHRI and BC Women’s Hospital + Health Centre. The search for Dr. Money’s replacement is currently underway.

Congratulations to WHRI Member Dr. Wendy Norman on receiving PHSA+ award

Dr. Wendy Norman

BC Women’s physician and WHRI Investigator, receives the prestigious Darroch Award for Excellence in Sexual and Reproductive Health Research.

Dr. Wendy Norman was awarded the prestigious Darroch Award on January 19 in New York City.

The Darroch Award, sponsored by the Guttmacher Institute, recognizes an emerging leader who is a researcher in the field of sexual and reproductive health, where scientific evidence is essential to guiding the policies and programs of the future.

Dr. Norman has leveraged her expertise, collaborations and trust established as a respected abortion provider and family physician, to effect change in the area of abortion and contraception health services in Canada.

Dr. Norman began her research career in October 2008, establishing partnerships with all relevant family planning health services, health decision leaders in the Ministry of Health and more than 11 disciplines of academic researchers in British Columbia (BC’s Contraception & Abortion Research Team (BC CART).

Within two years, the BC CART collaboration directed her to build and lead Canada’s national Contraception Access Research Team-Groupe de Recherche sur l’Accessibilité à la Contraception.

As a Women’s Health Research Institute (WHRI) Member, Dr. Norman’s first grant was bestowed by the institute, in February 2009. In just four years she personally led research awarded over $2 million, a ​more than 80 fold return on the seed grant investment.

Dr. Norman’s Family Planning Health Services Research program at BC Women’s comprises three themes:

Health policy research: Determination and effective translation of evidence to support health policy that will provide universal subsidy of contraception throughout Canada (where contraception is currently a consumer cost).

Health professional task-sharing to provide contraception and abortion access: Working with pharmacists, midwives, nurses and their regulatory organizations to collect and translate evidence supporting scope of practice changes.

Interdisciplinary health professional education: Improvement of physician, nursing, midwifery and pharmacist family planning education both pre-licensure and continuing professional education.

Congratulations Dr. Wendy Norman.

Women’s Health Recognized through CIHR Foundation and Operating Grants

Congratulations to Women’s Health Research Institute Members for their success in the recent CIHR Competition for Foundation and Operating Grants.

Dr. Gina Ogilvie

Dr. Gina Ogilvie
Dr. Gina Ogilvie

Dr. Gina Ogilvie, Senior Advisor, Research at BC Women’s Hospital + Health Centre and Assistant Director of the WHRI is awarded a Foundation Grant of $2,714,493 for the Integrated Global Control of HPV Related Diseases and Cancer research program. Over 5% of cancers worldwide are caused by the human papillomavirus (HPV). With this funding, Dr. Ogilvie and her team will lead a program of research to eradicate HPV cancers by creating policy relevant evidence through studies in both high and low/middle income countries which will guide implementation of prevention strategies for HPV related cancers.

Dr. Ogilvie has achieved a true milestone as this competition was the first of its kind in the CIHR foundation scheme.


Dr. Paul Yong

Dr. Paul Yong
Dr. Paul Yong

Dr. Paul Yong, Research Director and Physician at the Chronic Pelvic Pain program at BC Women’s Hospital and Health Centre has been awarded an Operating Grant of $282,868 to research the Etiology of Dyspareunia in Endometriosis. Endometriosis is known to cause pelvic pain during intercourse, which is known as dyspareunia. In fact, half of women with endometriosis experience dyspareunia. With this funding, Dr. Yong and his team will identify causes of dyspareunia in women with endometriosis. Ultimately, understanding the causes of dyspareunia will lead to better pain relief for patients.


Dr. Kate Shannon

Dr. Kate Shannon
Dr. Kate Shannon

Dr. Kate Shannon, Director of the Gender and Sexual Health Initiative and Canadian Research Chair for Global Sexual Health & HIV/AIDS has been awarded a Foundation Grant of $2,448,322 for Structural Determinants, Sexual Health and HIV/AIDS: Reducing Health & Social Inequities. With this funding, Dr. Shannon and her team will lead research to better understand and address gender-based gaps in sexual health and engagement in HIV care continuum for marginalized communities, including youth, women affected by or living with HIV, im/migrant and refugee women, and sex workers both in Canada and globally. This foundation grant will support building capacity in applied sexual health and knowledge translation between researchers, policy makers and affected communities to reduce health and social inequities.


Congratulations to our members on such a successful competition!

CIHR IRSC Logo   UBC Logo

WHRI Member Dr. Wendy Norman is being featured in Canadian Family Practice

WHRI researcher, Dr. Wendy Norman, is being featured in the current issue of the journal “Canadian Family Physician”.

Dr. Wendy Norman featured in Canadian Family Physician

Dr. Norman also is well known for her leadership in a national collaboration the Canadian Contraception Access Research Team (CART/ GRAC www.cart-grac.ubc.ca) which aims to ensure equal access to family planning knowledge and services available for women and families in Canada.

This article highlights Dr. Norman’s role as Chair for the Section of Researchers for the College of Family Physicians where they are working to give a more friendly face to clinician research.

Please follow the link below to learn more:
http://transcontinental.ipaperus.com/ecfp/jun15/

Congratulations to Dr. Denise Pugash for PRIME!

Canada Foundation for Innovation (CFI) awards UBC $827,000 for research in maternal and infant health taking place at BC Women’s Hospital.

Dr. D. Pugash

The funds were awarded to study recent advances in ultrasound technology through PRIME -Perinatal Research Imaging Evaluation which will be led by BC Women’s Radiologist, and UBC clinical professor, Dr. Denise Pugash.

The newly renovated PRIME Centre will be located in BC Women’s Hospital, adjacent to the clinical ultrasound department.

Each year, over 7,000 babies are delivered and 16,000 ultrasound exams are performed at BC Women’s. Half of these pregnancies are high-risk due to serious maternal conditions or fetal abnormalities.

For more information please follow the link below :
http://www.bcwomensfoundation.org/news/awards-and-accomplishments/articles/782.php